Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Genetics,Molecular Biology,Biochemistry
Reference15 articles.
1. Miller, R. G., Mitchell, J. D. & Moore, D. H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 2012, CD001447 (2012).
2. Liu, J. & Wang, L. N. The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis. Drug Deliv. 25, 43–48 (2018).
3. Zarate, C. A. & Manji, H. K. Riluzole in psychiatry: a systematic review of the literature. Expert. Opin. Drug Metab. Toxicol. 4, 1223–1234 (2008).
4. Richter, J. M., Schaefer, M. & Hill, K. Riluzole activates TRPC5 channels independently of PLC activity. Br. J. Pharmacol. 171, 158–170 (2014).
5. Zholos, A. V. TRPC5. Handb. Exp. Pharmacol. 222, 129–156 (2014).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献